{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T23:35:27Z","timestamp":1791243327831,"version":"4.1.0"},"reference-count":50,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2017,6,15]],"date-time":"2017-06-15T00:00:00Z","timestamp":1497484800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2017,6,15]],"date-time":"2017-06-15T00:00:00Z","timestamp":1497484800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["2R01NS066927"],"award-info":[{"award-number":["2R01NS066927"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Clin Transl Neurol"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1002\/acn3.432","type":"journal-article","created":{"date-parts":[[2017,6,15]],"date-time":"2017-06-15T22:32:40Z","timestamp":1497565960000},"page":"601-607","source":"Crossref","is-referenced-by-count":29,"title":["Caveats in the Established Understanding of CMT1A"],"prefix":"10.1002","volume":"4","author":[{"given":"Jun","family":"Li","sequence":"first","affiliation":[{"name":"Department of Neurology; Center for Human Genetic Research; and Vanderbilt Brain Institute; Vanderbilt University School of Medicine; Nashville Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,6,15]]},"reference":[{"key":"10.1002\/acn3.432-BIB0001|acn3432-cit-0001","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1093\/brain\/awu071","article-title":"PMP22 messenger RNA levels in skin biopsies: testing the effectiveness of a Charcot-Marie-Tooth 1A biomarker","volume":"137","author":"Nobbio","year":"2014","journal-title":"Brain"},{"key":"10.1002\/acn3.432-BIB0002|acn3432-cit-0002","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1111\/ene.13079","article-title":"Nerve conduction velocity in CMT1A: what else can we tell?","volume":"23","author":"Manganelli","year":"2016","journal-title":"Eur J Neurol"},{"key":"10.1002\/acn3.432-BIB0003|acn3432-cit-0003","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1093\/brain\/awp113","article-title":"PMP22 expression in dermal nerve myelin from patients with CMT1A","volume":"132","author":"Katona","year":"2009","journal-title":"Brain"},{"key":"10.1002\/acn3.432-BIB0004|acn3432-cit-0004","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1093\/brain\/awh483","article-title":"Skin biopsies in myelin-related neuropathies: bringing molecular pathology to the bedside","volume":"128","author":"Li","year":"2005","journal-title":"Brain"},{"key":"10.1002\/acn3.432-BIB0005|acn3432-cit-0005","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1212\/WNL.32.6.592","article-title":"The electrodiagnostic distinctions between chronic familial and acquired demyelinative neuropathies","volume":"32","author":"Lewis","year":"1982","journal-title":"Neurology"},{"key":"10.1002\/acn3.432-BIB0006|acn3432-cit-0006","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1002\/jnr.10133","article-title":"Proliferation of Schwann cells and regulation of cyclin D1 expression in an animal model of Charcot-Marie-Tooth disease type 1A","volume":"67","author":"Atanasoski","year":"2002","journal-title":"J Neurosci Res"},{"issue":"Pt 3","key":"10.1002\/acn3.432-BIB0007|acn3432-cit-0007","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1093\/brain\/120.3.465","article-title":"The phenotypic manifestations of chromosome 17p11.2 duplication","volume":"120","author":"Thomas","year":"1997","journal-title":"Brain"},{"key":"10.1002\/acn3.432-BIB0008|acn3432-cit-0008","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1046\/j.1469-7580.2002.00039.x","article-title":"Comparison of a new pmp22 transgenic mouse line with other mouse models and human patients with CMT1A","volume":"200","author":"Robertson","year":"2002","journal-title":"J Anat"},{"key":"10.1002\/acn3.432-BIB0009|acn3432-cit-0009","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1212\/WNL.43.9.1806","article-title":"Nerve conduction studies in Charcot-Marie-Tooth polyneuropathy associated with a segmental duplication of chromosome 17","volume":"43","author":"Kaku","year":"1993","journal-title":"Neurology"},{"key":"10.1002\/acn3.432-BIB0010|acn3432-cit-0010","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1212\/WNL.41.4.547","article-title":"Penetrance of the hereditary motor and sensory neuropathy Ia mutation: assessment by nerve conduction studies","volume":"41","author":"Nicholson","year":"1991","journal-title":"Neurology"},{"key":"10.1002\/acn3.432-BIB0011|acn3432-cit-0011","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/j.1749-6632.1999.tb08618.x","article-title":"Correlation between weakness and axonal loss in patients with CMT1A","volume":"883","author":"Krajewski","year":"1999","journal-title":"Ann N Y Acad Sci"},{"issue":"Pt 7","key":"10.1002\/acn3.432-BIB0012|acn3432-cit-0012","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1093\/brain\/123.7.1516","article-title":"Neurological dysfunction and axonal degeneration in Charcot-Marie-Tooth disease type 1A","volume":"123","author":"Krajewski","year":"2000","journal-title":"Brain"},{"issue":"Pt 5","key":"10.1002\/acn3.432-BIB0013|acn3432-cit-0013","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1093\/brain\/120.5.813","article-title":"Charcot-Marie-Tooth disease type 1A with 17p11.2 duplication. Clinical and electrophysiological phenotype study and factors influencing disease severity in 119 cases","volume":"120","author":"Birouk","year":"1997","journal-title":"Brain"},{"key":"10.1002\/acn3.432-BIB0014|acn3432-cit-0014","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S1474-4422(09)70108-5","article-title":"Ascorbic acid for Charcot-Marie-Tooth disease type 1A in children: a randomised, double-blind, placebo-controlled, safety and efficacy trial","volume":"8","author":"Burns","year":"2009","journal-title":"Lancet Neurol"},{"key":"10.1002\/acn3.432-BIB0015|acn3432-cit-0015","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/BF00318579","article-title":"Charcot-Marie-Tooth disease type 1A: morphological phenotype of the 17p duplication versus PMP22 point mutations","volume":"90","author":"Gabreels-Festen","year":"1995","journal-title":"Acta Neuropathol"},{"key":"10.1002\/acn3.432-BIB0016|acn3432-cit-0016","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/j.1749-6632.1999.tb08595.x","article-title":"Human nerve pathology caused by different mutational mechanisms of the PMP22 gene","volume":"883","author":"Gabreels-Festen","year":"1999","journal-title":"Ann N Y Acad Sci"},{"key":"10.1002\/acn3.432-BIB0017|acn3432-cit-0017","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1152\/ajplegacy.1939.127.2.393","article-title":"Axon diameter in relation to the spike dimentions and conduction velocity in Mammalian A fibers","volume":"127","author":"Gasser","year":"1939","journal-title":"Am J Physiol"},{"key":"10.1002\/acn3.432-BIB0018|acn3432-cit-0018","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.expneurol.2015.03.009","article-title":"Molecular Regulators of Nerve Conduction - Lessons from Inherited Neuropathies and Rodent Genetic Models","volume":"267","author":"Li","year":"2015","journal-title":"Exp Neurol"},{"key":"10.1002\/acn3.432-BIB0019|acn3432-cit-0019","doi-asserted-by":"crossref","first-page":"3263","DOI":"10.1093\/brain\/awp274","article-title":"Shortened internodal length of dermal myelinated nerve fibres in Charcot-Marie-Tooth disease type 1A","volume":"132","author":"Saporta","year":"2009","journal-title":"Brain"},{"key":"10.1002\/acn3.432-BIB0020|acn3432-cit-0020","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1038\/nm.3664","article-title":"Soluble neuregulin-1 modulates disease pathogenesis in rodent models of Charcot-Marie-Tooth disease 1A","volume":"20","author":"Fledrich","year":"2014","journal-title":"Nat Med"},{"key":"10.1002\/acn3.432-BIB0021|acn3432-cit-0021","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1126\/science.1095862","article-title":"Axonal neuregulin-1 regulates myelin sheath thickness","volume":"304","author":"Michailov","year":"2004","journal-title":"Science"},{"key":"10.1002\/acn3.432-BIB0022|acn3432-cit-0022","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1002\/(SICI)1097-4598(199807)21:7<869::AID-MUS4>3.0.CO;2-4","article-title":"Clinical and pathological correlations in Charcot-Marie-Tooth neuropathy type 1A with the 17p11.2p12 duplication: a cross-sectional morphometric and immunohistochemical study in twenty cases","volume":"21","author":"Fabrizi","year":"1998","journal-title":"Muscle Nerve"},{"key":"10.1002\/acn3.432-BIB0023|acn3432-cit-0023","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1080\/21548331.1997.11443485","article-title":"Charcot-Marie-Tooth disease: a gene-dosage effect","volume":"32","author":"Lupski","year":"1997","journal-title":"Hosp Pract (Off Ed)"},{"key":"10.1002\/acn3.432-BIB0024|acn3432-cit-0024","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1002\/ana.410390621","article-title":"Ultrastructural PMP22 expression in inherited demyelinating neuropathies","volume":"39","author":"Vallat","year":"1996","journal-title":"Ann Neurol"},{"key":"10.1002\/acn3.432-BIB0025|acn3432-cit-0025","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1212\/WNL.0000000000001470","article-title":"Genetic dosage compensation via co-occurrence of PMP22 duplication and PMP22 deletion","volume":"84","author":"Hirt","year":"2015","journal-title":"Neurology"},{"key":"10.1002\/acn3.432-BIB0026|acn3432-cit-0026","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1038\/ng1896","article-title":"Nuclear organization of active and inactive chromatin domains uncovered by chromosome conformation capture-on-chip (4C)","volume":"38","author":"Simonis","year":"2006","journal-title":"Nat Genet"},{"key":"10.1002\/acn3.432-BIB0027|acn3432-cit-0027","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1101\/gr.5571506","article-title":"Chromosome Conformation Capture Carbon Copy (5C): a massively parallel solution for mapping interactions between genomic elements","volume":"16","author":"Dostie","year":"2006","journal-title":"Genome Res"},{"key":"10.1002\/acn3.432-BIB0028|acn3432-cit-0028","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1126\/science.1067799","article-title":"Capturing chromosome conformation","volume":"295","author":"Dekker","year":"2002","journal-title":"Science"},{"key":"10.1002\/acn3.432-BIB0029|acn3432-cit-0029","doi-asserted-by":"crossref","first-page":"23146","DOI":"10.1074\/jbc.M109.027128","article-title":"P2X7-mediated increased intracellular calcium causes functional derangement in Schwann cells from rats with CMT1A neuropathy","volume":"284","author":"Nobbio","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1002\/acn3.432-BIB0030|acn3432-cit-0030","doi-asserted-by":"crossref","first-page":"5351","DOI":"10.1523\/JNEUROSCI.16-17-05351.1996","article-title":"Impaired differentiation of Schwann cells in transgenic mice with increased PMP22 gene dosage","volume":"16","author":"Magyar","year":"1996","journal-title":"J Neurosci"},{"key":"10.1002\/acn3.432-BIB0031|acn3432-cit-0031","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1093\/brain\/awf230","article-title":"PMP22 overexpression causes dysmyelination in mice","volume":"125","author":"Robaglia-Schlupp","year":"2002","journal-title":"Brain"},{"key":"10.1002\/acn3.432-BIB0032|acn3432-cit-0032","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0896-6273(00)80128-2","article-title":"A transgenic rat model of Charcot-Marie-Tooth disease","volume":"16","author":"Sereda","year":"1996","journal-title":"Neuron"},{"key":"10.1002\/acn3.432-BIB0033|acn3432-cit-0033","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1093\/hmg\/10.10.1007","article-title":"Induced myelination and demyelination in a conditional mouse model of Charcot-Marie-Tooth disease type 1A","volume":"10","author":"Perea","year":"2001","journal-title":"Hum Mol Genet"},{"key":"10.1002\/acn3.432-BIB0034|acn3432-cit-0034","doi-asserted-by":"crossref","first-page":"4382","DOI":"10.1073\/pnas.89.10.4382","article-title":"A leucine-to-proline mutation in the putative first transmembrane domain of the 22-kDa peripheral myelin protein in the trembler-J mouse","volume":"89","author":"Suter","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1002\/acn3.432-BIB0035|acn3432-cit-0035","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1523\/JNEUROSCI.3328-04.2005","article-title":"Altered ion channels in an animal model of Charcot-Marie-Tooth disease type IA","volume":"25","author":"Devaux","year":"2005","journal-title":"J Neurosci"},{"key":"10.1002\/acn3.432-BIB0036|acn3432-cit-0036","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.nbd.2004.10.023","article-title":"Distinct disease mechanisms in peripheral neuropathies due to altered peripheral myelin protein 22 gene dosage or a Pmp22 point mutation","volume":"18","author":"Giambonini-Brugnoli","year":"2005","journal-title":"Neurobiol Dis"},{"key":"10.1002\/acn3.432-BIB0037|acn3432-cit-0037","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1006\/nbdi.2000.0323","article-title":"PMP22 carrying the trembler or trembler-J mutation is intracellularly retained in myelinating Schwann cells","volume":"7","author":"Colby","year":"2000","journal-title":"Neurobiol Dis"},{"key":"10.1002\/acn3.432-BIB0038|acn3432-cit-0038","doi-asserted-by":"crossref","first-page":"9852","DOI":"10.1073\/pnas.152621799","article-title":"Association of calnexin with mutant peripheral myelin protein-22 ex vivo: a basis for \u201cgain-of-function\u201d ER diseases","volume":"99","author":"Dickson","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1002\/acn3.432-BIB0039|acn3432-cit-0039","doi-asserted-by":"crossref","first-page":"4190","DOI":"10.1523\/JNEUROSCI.17-11-04190.1997","article-title":"Upregulation of the endosomal-lysosomal pathway in the trembler-J neuropathy","volume":"17","author":"Notterpek","year":"1997","journal-title":"J Neurosci"},{"key":"10.1002\/acn3.432-BIB0040|acn3432-cit-0040","doi-asserted-by":"crossref","first-page":"10672","DOI":"10.1523\/JNEUROSCI.23-33-10672.2003","article-title":"Emerging role for autophagy in the removal of aggresomes in Schwann cells","volume":"23","author":"Fortun","year":"2003","journal-title":"J Neurosci"},{"key":"10.1002\/acn3.432-BIB0041|acn3432-cit-0041","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.nbd.2006.09.018","article-title":"The formation of peripheral myelin protein 22 aggregates is hindered by the enhancement of autophagy and expression of cytoplasmic chaperones","volume":"25","author":"Fortun","year":"2007","journal-title":"Neurobiol Dis"},{"issue":"Pt 5","key":"10.1002\/acn3.432-BIB0042|acn3432-cit-0042","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1093\/brain\/123.5.1001","article-title":"Mutation-dependent alteration in cellular distribution of peripheral myelin protein 22 in nerve biopsies from Charcot-Marie-Tooth type 1A","volume":"123","author":"Hanemann","year":"2000","journal-title":"Brain"},{"key":"10.1002\/acn3.432-BIB0043|acn3432-cit-0043","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.nmd.2006.12.008","article-title":"Ascorbic acid inhibits PMP22 expression by reducing cAMP levels","volume":"17","author":"Kaya","year":"2007","journal-title":"Neuromuscul Disord"},{"key":"10.1002\/acn3.432-BIB0044|acn3432-cit-0044","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/0012-1606(89)90043-2","article-title":"Cultured Schwann cells assemble normal-appearing basal lamina only when they ensheathe axons","volume":"133","author":"Clark","year":"1989","journal-title":"Dev Biol"},{"key":"10.1002\/acn3.432-BIB0045|acn3432-cit-0045","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1083\/jcb.109.1.273","article-title":"Movements of the Schwann cell nucleus implicate progression of the inner (axon-related) Schwann cell process during myelination","volume":"109","author":"Bunge","year":"1989","journal-title":"J Cell Biol"},{"key":"10.1002\/acn3.432-BIB0046|acn3432-cit-0046","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1038\/nm957","article-title":"Therapeutic administration of progesterone antagonist in a model of Charcot-Marie-Tooth disease (CMT-1A)","volume":"9","author":"Sereda","year":"2003","journal-title":"Nat Med"},{"key":"10.1002\/acn3.432-BIB0047|acn3432-cit-0047","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/nm1023","article-title":"Ascorbic acid treatment corrects the phenotype of a mouse model of Charcot-Marie-Tooth disease","volume":"10","author":"Passage","year":"2004","journal-title":"Nat Med"},{"key":"10.1002\/acn3.432-BIB0048|acn3432-cit-0048","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S1474-4422(11)70025-4","article-title":"Ascorbic acid in Charcot-Marie-Tooth disease type 1A (CMT-TRIAAL and CMT-TRAUK): a double-blind randomised trial","volume":"10","author":"Pareyson","year":"2011","journal-title":"Lancet Neurol"},{"key":"10.1002\/acn3.432-BIB0049|acn3432-cit-0049","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1001\/jamaneurol.2013.3178","article-title":"High-dosage ascorbic acid treatment in Charcot-Marie-Tooth disease type 1A: results of a randomized, double-masked, controlled trial","volume":"70","author":"Lewis","year":"2013","journal-title":"JAMA Neurol"},{"key":"10.1002\/acn3.432-BIB0050|acn3432-cit-0050","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1021\/cb300048d","article-title":"Identification of drug modulators targeting gene-dosage disease CMT1A","volume":"7","author":"Jang","year":"2012","journal-title":"ACS Chem Biol"}],"container-title":["Annals of Clinical and Translational Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Facn3.432","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/acn3.432","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T10:36:34Z","timestamp":1625135794000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/acn3.432"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,15]]},"references-count":50,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,8]]}},"URL":"https:\/\/doi.org\/10.1002\/acn3.432","archive":["Portico"],"relation":{},"ISSN":["2328-9503"],"issn-type":[{"value":"2328-9503","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6,15]]}}}